| 181 |
Vascular endothelial growth factor & basic fibroblast
growth factor polymorphism as prognostic factors in
Non-Hodgkin Lymphoma |
2018 |
| 182 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
2018 |
| 183 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
2018 |
| 184 |
Association of peripheral NK cell counts with Helios+IFNy- Tregs in patients with good long-term renal allograft function |
2017 |
| 185 |
Association of serum fibroblast growth factor-23 with
conventional cardiovascular risk factors in hemodialysis
patients |
2017 |
| 186 |
Association of serum fibroblast growth factor-23 with
conventional cardiovascular risk factors in hemodialysis
patients |
2017 |
| 187 |
B-lymphocyte stimulator: can we consider it a marker
for severity of hepatitis C virus-induced B-cell non-Hodgkin
lymphoma? |
2017 |
| 188 |
B-lymphocyte stimulator: can we consider it a marker
for severity of hepatitis C virus-induced B-cell non-Hodgkin
lymphoma? |
2017 |
| 189 |
B-lymphocyte stimulator: can we consider it a marker
for severity of hepatitis C virus-induced B-cell non-Hodgkin
lymphoma? |
2017 |
| 190 |
Correlation of anti-cardiolipin antibodies with right ventricular systolic
strain in systemic lupus erythematosus patients |
2017 |
هل لديك سؤال ؟
